(Total Views: 473)
Posted On: 08/17/2019 9:20:49 AM
Post# of 150370
Just ran across this. Shows leronlimab should work on primary tumors.
https://www.ncbi.nlm.nih.gov/pubmed/23526353
Quote:
Our results indicate that CCR5 has a critical role in both the development and progression of liver cancer. Therefore, we propose that a CCR5 antagonist can serve for HCC cancer prevention and treatment.
https://www.ncbi.nlm.nih.gov/pubmed/23526353
(2)
(0)Scroll down for more posts ▼
